Phase II Safety/Efficacy Study of A Combination Stem Cell Therapy That Develops Mature Stable Vessel Formation in Ischemic Limbs

Trial Profile

Phase II Safety/Efficacy Study of A Combination Stem Cell Therapy That Develops Mature Stable Vessel Formation in Ischemic Limbs

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Jun 2014

At a glance

  • Drugs Autologous stem cell therapy (Primary)
  • Indications Peripheral ischaemia
  • Focus Therapeutic Use
  • Sponsors TCA Cellular Therapy
  • Most Recent Events

    • 16 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top